Kenvue Inc. (KVUE) Price and Market Data

Kenvue Inc. is the world’s largest pure-play consumer health company by sales, generating more than $15 billion in annual revenue. Formerly Johnson & Johnson’s consumer health segment, Kenvue was spun off and became a public company in May 2023. The company operates across multiple consumer health categories, including cough, cold and allergy care, pain relief, face and body care, oral care, and women’s health. Its portfolio includes some of the industry’s best-known brands, such as Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. In November 2025, Kenvue announced an agreement to be fully acquired by Kimberly-Clark, with the transaction expected to close in the second half of 2026.